- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 6, 2020
Translation in Brief
Engineered bacteria for targeted bacterial killing; plus Cas12a base editors, base editing to restore hearing and more
BioCentury’s roundup of preclinical news
BioCentury | Jul 25, 2019
Distillery Therapeutics
TMC1 gene editing therapy for dominant progressive hearing loss
BioCentury | Feb 2, 2018
Tools & Techniques
Cutting a new path
Where gene editing therapies are heading next
BioCentury | Aug 13, 2015
Distillery Therapeutics
Therapeutics: Transmembrane channel-like-1 (TMC1); TMC2
BioCentury | Aug 13, 2015
Tools & Techniques
Helping Beethoven hear
How gene therapy could become the first therapeutic for genetic hearing loss
Items per page:
1 - 7 of 7